ArticlePlastic and reconstructive surgery. Global open2025

Considerations for the Use of Glucagon-like Peptide-1 Medications for Obesity in a Plastic Surgery Setting.

Leah M Schumacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.